Diagnostics play Clinical Genomics raises $15M

Clinical Genomics Pty. Ltd. (North Ryde, Australia) closed a $15 million series A round led by Australian venture firm OneVentures.

This year, Clinical Genomics plans to launch its Gemini test in the U.S. for post-surgical monitoring of colorectal cancer (CRC) recurrence. The blood test detects tumor-specific methylated cytosolic branched chain amino-acid transaminase 1 ( BCAT1) and IKAROS family zinc finger 1 ( IKZF1; LYF1). ...